Kelderman Kim 4

What Happened

• Kim Kelderman, CEO of Bio-Techne (TECH), exercised stock options on 2026-05-05 to acquire 26,692 shares at an exercise price of $47.60 per share, costing $1,270,539.
• To cover exercise costs and tax withholding, 23,951 of those shares were withheld/sold at an effective value of $56.68 per share (total value reported $1,357,543). Net shares retained from this transaction: 2,741 shares (26,692 acquired minus 23,951 withheld).
• The filing shows the derivative/option conversion and the tax/withholding event; this is a routine cashless/sell-to-cover exercise rather than an open‑market purchase.

Key Details

• Transaction date: 2026-05-05; Form 4 filed 2026-05-07 (appears timely).
• Exercise: 26,692 shares @ $47.60 = $1,270,539 (code M — option exercise).
• Withholding/sale for taxes/exercise: 23,951 shares @ $56.68 = $1,357,543 (code F — payment of exercise price or tax liability).
• Net shares retained from this exercise: 2,741 shares.
• Footnote(s): F1 indicates the options were fully exercisable. (Other listed footnotes in the filing describe vesting schedules for other awards but are not directly tied to the May 5 transactions provided.)
• Shares owned after transaction: Not specified in the provided filing excerpt.

Context

• This was an option exercise followed by a sell-to-cover (shares withheld/sold to pay taxes and/or exercise price). That’s a common way insiders exercise options without depositing cash.
• Such sell-to-cover transactions are routine and do not necessarily signal the insider’s view on the stock; they primarily satisfy tax and payment obligations.
• No late filing is indicated from the dates provided.